Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ)
CNY 22.15
(0.23%)
CNY 22.15
(0.23%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.06 Billion CNY | 13.58% |
| 2022 | 934.38 Million CNY | 11.05% |
| 2021 | 841.41 Million CNY | -6.65% |
| 2020 | 901.33 Million CNY | 0.0% |
| 2019 | - CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| 2015 | - CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| 2012 | - CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| 2010 | - CNY | 0.0% |
| 2009 | - CNY | 0.0% |
| 2008 | - CNY | -100.0% |
| 2007 | 5 Million CNY | 0.0% |
| 2006 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 1.07 Billion CNY | 0.85% |
| 2024 Q3 | 1.03 Billion CNY | 0.88% |
| 2024 Q2 | 1.02 Billion CNY | -4.59% |
| 2023 Q4 | 1.06 Billion CNY | -0.04% |
| 2023 Q3 | 1.06 Billion CNY | 0.85% |
| 2023 Q2 | 1.05 Billion CNY | 0.81% |
| 2023 Q1 | 1.04 Billion CNY | 11.77% |
| 2023 FY | 1.06 Billion CNY | 13.58% |
| 2022 Q2 | 928.11 Million CNY | 5.1% |
| 2022 Q4 | 934.38 Million CNY | 3.53% |
| 2022 FY | 934.38 Million CNY | 11.05% |
| 2022 Q3 | 902.48 Million CNY | -2.76% |
| 2022 Q1 | 883.05 Million CNY | 4.95% |
| 2021 Q4 | 841.41 Million CNY | -9.56% |
| 2021 Q1 | 915.81 Million CNY | 1.61% |
| 2021 Q2 | 921.83 Million CNY | 0.66% |
| 2021 Q3 | 930.41 Million CNY | 0.93% |
| 2021 FY | 841.41 Million CNY | -6.65% |
| 2020 FY | 901.33 Million CNY | 0.0% |
| 2020 Q4 | 901.33 Million CNY | 10.71% |
| 2020 Q2 | 110.04 Million CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 Q3 | 814.16 Million CNY | 639.85% |
| 2019 Q4 | - CNY | 0.0% |
| 2019 Q2 | - CNY | -100.0% |
| 2019 FY | - CNY | 0.0% |
| 2019 Q3 | - CNY | 0.0% |
| 2019 Q1 | 1.00 CNY | 0.0% |
| 2018 Q3 | - CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2018 Q2 | - CNY | 0.0% |
| 2017 Q3 | - CNY | 0.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2017 Q1 | - CNY | 0.0% |
| 2017 Q2 | - CNY | 0.0% |
| 2016 Q2 | - CNY | 0.0% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| 2016 Q3 | - CNY | 0.0% |
| 2016 Q4 | - CNY | 0.0% |
| 2015 Q4 | - CNY | 0.0% |
| 2015 Q3 | - CNY | 0.0% |
| 2015 Q2 | - CNY | -100.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 FY | - CNY | 0.0% |
| 2014 Q3 | - CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2014 Q2 | - CNY | 0.0% |
| 2014 Q4 | - CNY | 0.0% |
| 2013 Q4 | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |
| 2013 Q3 | - CNY | 0.0% |
| 2013 Q2 | - CNY | 0.0% |
| 2013 Q1 | - CNY | 0.0% |
| 2012 Q3 | - CNY | 0.0% |
| 2012 Q2 | - CNY | 0.0% |
| 2012 FY | - CNY | 0.0% |
| 2012 Q4 | - CNY | 0.0% |
| 2012 Q1 | - CNY | 0.0% |
| 2011 Q4 | - CNY | 0.0% |
| 2011 Q2 | - CNY | 0.0% |
| 2011 Q3 | - CNY | 0.0% |
| 2011 Q1 | - CNY | 0.0% |
| 2011 FY | - CNY | 0.0% |
| 2010 Q1 | - CNY | 0.0% |
| 2010 Q2 | - CNY | 0.0% |
| 2010 FY | - CNY | 0.0% |
| 2010 Q4 | - CNY | 0.0% |
| 2010 Q3 | - CNY | 0.0% |
| 2009 FY | - CNY | 0.0% |
| 2009 Q3 | - CNY | 0.0% |
| 2009 Q2 | - CNY | 0.0% |
| 2009 Q4 | - CNY | 0.0% |
| 2008 Q4 | - CNY | 0.0% |
| 2008 FY | - CNY | -100.0% |
| 2007 FY | 5 Million CNY | 0.0% |
| 2006 FY | - CNY | 0.0% |